Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of ASA after warfarin for unprovoked VTE.

Literature DB >> 24130282

Use of ASA after warfarin for unprovoked VTE.

G Michael Allan, Hoan Linh Banh, Jonathan Ference.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2013 PMID： 24130282 PMCID： PMC3796973

Source DB: PubMed Journal: Can Fam Physician ISSN： 0008-350X Impact factor: 3.275

Keyword Cloud
References

× No keyword cloud information.

9 in total

1. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal: Chest Date: 2012-02 Impact factor: 9.410

Review 2. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

Authors: B A Hutten; M H Prins
Journal: Cochrane Database Syst Rev Date: 2006-01-25

3. Aspirin for preventing the recurrence of venous thromboembolism.

Authors: Cecilia Becattini; Giancarlo Agnelli; Alessandro Schenone; Sabine Eichinger; Eugenio Bucherini; Mauro Silingardi; Marina Bianchi; Marco Moia; Walter Ageno; Maria Rita Vandelli; Elvira Grandone; Paolo Prandoni
Journal: N Engl J Med Date: 2012-05-24 Impact factor: 91.245

4. Oral rivaroxaban for symptomatic venous thromboembolism.

Authors: Rupert Bauersachs; Scott D Berkowitz; Benjamin Brenner; Harry R Buller; Hervé Decousus; Alex S Gallus; Anthonie W Lensing; Frank Misselwitz; Martin H Prins; Gary E Raskob; Annelise Segers; Peter Verhamme; Phil Wells; Giancarlo Agnelli; Henri Bounameaux; Alexander Cohen; Bruce L Davidson; Franco Piovella; Sebastian Schellong
Journal: N Engl J Med Date: 2010-12-03 Impact factor: 91.245

5. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Authors: Paolo Prandoni; Franco Noventa; Angelo Ghirarduzzi; Vittorio Pengo; Enrico Bernardi; Raffaele Pesavento; Matteo Iotti; Daniela Tormene; Paolo Simioni; Antonio Pagnan
Journal: Haematologica Date: 2007-02 Impact factor: 9.941

Use of ASA after warfarin for unprovoked VTE.

1. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Review 2. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

3. Aspirin for preventing the recurrence of venous thromboembolism.

4. Oral rivaroxaban for symptomatic venous thromboembolism.

5. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

6. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

7. Apixaban for extended treatment of venous thromboembolism.

8. Low-dose aspirin for preventing recurrent venous thromboembolism.

Review 9. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.